• Buy 1 Get 1 FREE for immortalized cells| limited time until end of June

  • Boost Your Research with FREE Freezing Medium

Stem Cells

HighQC™ Human IPSC From Fibroblast-Dystrophia Myotonica 1

  • For research use only

Cat No.

ABC-SC2048

Product Type

Human iPSCs

Cell Type

Induced Pluripotent Stem Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Fibroblast

Disease

Dystrophia Myotonica 1

Storage

Liquid Nitrogen

Cell Type: iPSC; Disease: Dystrophia Myotonica 1; DM1.

Product Image

Description

HighQC™ Human IPSC From Fibroblast-Dystrophia Myotonica 1 is a disease-specific induced pluripotent stem cell line generated from dermal fibroblasts of a donor diagnosed with Myotonic Dystrophy Type 1 (DM1). The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth and retain the fundamental capacity for trilineage differentiation into ectoderm, mesoderm, and endoderm derivatives. These iPSCs express the core pluripotency marker SSEA-4. They retain DM1-related cellular features and reflect neuromuscular physiology in vivo. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

HighQC™ Human IPSC From Fibroblast-Dystrophia Myotonica 1, HighQC™ hiPSC DM1, hiPSC-DM1, HighQC™ Human Induced Pluripotent Stem Cells From Fibroblast-Myotonic Dystrophy Type 1

Species

Human

Cat.No

ABC-SC2048

Product Category

Stem Cells

Size/Quantity

1 vial

Cell Type

Induced Pluripotent Stem Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Fibroblast

Disease

Dystrophia Myotonica 1

Storage

Liquid Nitrogen

Product Type

Human iPSCs

Application

  • HighQC™ Human IPSC From Fibroblast-Dystrophia Myotonica 1 serves as a human disease model for developmental and mechanistic studies. Its pluripotent capacity enables differentiation into skeletal muscle cells, cardiomyocytes, and neurons — key lineages affected in myotonic dystrophy type 1 (DM1). This system is used to model multi-systemic pathology, study the toxic effects of expanded Cytosine-Thymine-Guanine (CTG) repeats, and perform drug screening in patient-specific skeletal muscle or cardiac organoids, aiding research into RNA toxicity, muscle development, and cardiac conduction abnormalities.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring HighQC™ Human IPSC From Fibroblast-Dystrophia Myotonica 1

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button